Translations:Ipragliflozin/7/en: Difference between revisions
Jump to navigation
Jump to search
Importing a new version from external source Tags: Mobile edit Mobile web edit |
(No difference)
|
Latest revision as of 21:00, 20 February 2024
Ipragliflozin is a Sodium/glucose cotransporter 2 (SGLT2) inhibitor (gliflozin). These membrane proteins are on the cell surface and transfer glucose into the cells. SGLT2 is one subtype of SGLTs and plays a key role in the reuptake of glucose in the proximal tubule of the kidneys. Ipragliflozin reduces blood glucose levels by inhibiting the reuptake of glucose by selectively inhibiting SGLT2.